Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,643 | 227 | 99.9% |
| Education | $4.69 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $656.61 | 53 | $0 (2024) |
| Lilly USA, LLC | $453.56 | 35 | $0 (2024) |
| Novo Nordisk Inc | $423.70 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $385.85 | 18 | $0 (2024) |
| ABBVIE INC. | $268.87 | 11 | $0 (2024) |
| Amgen Inc. | $224.59 | 9 | $0 (2018) |
| ARBOR PHARMACEUTICALS, INC. | $207.15 | 13 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $114.88 | 8 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $80.50 | 4 | $0 (2023) |
| Allergan, Inc. | $78.01 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $413.54 | 21 | ABBVIE INC. ($144.25) |
| 2023 | $354.37 | 19 | AbbVie Inc. ($72.75) |
| 2022 | $166.25 | 10 | Novo Nordisk Inc ($57.54) |
| 2021 | $584.32 | 42 | PFIZER INC. ($189.84) |
| 2020 | $597.04 | 39 | Lilly USA, LLC ($165.77) |
| 2019 | $234.12 | 19 | PFIZER INC. ($128.32) |
| 2018 | $550.83 | 32 | Amgen Inc. ($152.96) |
| 2017 | $747.54 | 46 | AstraZeneca Pharmaceuticals LP ($172.83) |
All Payment Transactions
228 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Obesity | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Diabetes | ||||||
| 10/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.78 | General |
| Category: PSYCHIATRY | ||||||
| 08/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/02/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Diabetes | ||||||
| 07/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Oncology | ||||||
| 06/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Respiratory | ||||||
| 05/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardio-renal | ||||||
| 05/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.13 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Cardio-renal | ||||||
| 02/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Cardio-renal | ||||||
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.13 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Diabetes | ||||||
| 12/15/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Respiratory | ||||||
| 11/13/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Oncology | ||||||
| 11/03/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,462 | 2,395 | $270,652 | $112,348 |
| 2022 | 25 | 1,747 | 2,855 | $280,095 | $117,551 |
| 2021 | 27 | 2,281 | 3,795 | $373,568 | $164,847 |
| 2020 | 31 | 1,699 | 2,514 | $248,294 | $92,439 |
All Medicare Procedures & Services
107 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 227 | 342 | $60,370 | $25,801 | 42.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 145 | 224 | $43,270 | $25,584 | 59.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 234 | 406 | $55,310 | $22,364 | 40.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 159 | 251 | $28,910 | $8,085 | 28.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 76 | $12,710 | $4,473 | 35.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 45 | $12,195 | $4,300 | 35.3% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 92 | 92 | $3,355 | $3,076 | 91.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 23 | 23 | $4,400 | $2,624 | 59.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 92 | 92 | $2,760 | $2,616 | 94.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 28 | 33 | $5,929 | $1,976 | 33.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 27 | 27 | $2,565 | $1,796 | 70.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 17 | 21 | $4,914 | $1,746 | 35.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 29 | 38 | $4,140 | $1,329 | 32.1% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 111 | 286 | $5,720 | $1,297 | 22.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 86 | $3,870 | $1,155 | 29.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 19 | 35 | $3,325 | $1,006 | 30.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 20 | 28 | $4,140 | $961.96 | 23.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 24 | $3,260 | $881.52 | 27.0% |
| 85610 | Blood test, clotting time | Office | 2023 | 18 | 123 | $4,305 | $509.02 | 11.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 27 | 32 | $1,440 | $304.64 | 21.2% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 47 | 59 | $1,475 | $232.46 | 15.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 17 | 17 | $639.00 | $97.28 | 15.2% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 17 | 17 | $765.00 | $70.56 | 9.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 13 | 18 | $885.00 | $63.18 | 7.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 265 | 405 | $67,390 | $29,307 | 43.5% |
About Dr. Johnnie Carter, MD
Dr. Johnnie Carter, MD is a Family Medicine healthcare provider based in Athens, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558458257.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Johnnie Carter, MD has received a total of $3,648 in payments from pharmaceutical and medical device companies, with $413.54 received in 2024. These payments were reported across 228 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,643).
As a Medicare-enrolled provider, Carter has provided services to 7,189 Medicare beneficiaries, totaling 11,559 services with total Medicare billing of $487,186. Data is available for 4 years (2020–2023), covering 107 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Athens, TN
- Active Since 10/06/2006
- Last Updated 11/30/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558458257
Products in Payments
- Ozempic (Drug) $323.15
- VRAYLAR (Drug) $273.94
- TRULICITY (Drug) $272.55
- CHANTIX (Drug) $239.45
- Prolia (Biological) $224.59
- ELIQUIS (Drug) $174.16
- FARXIGA (Drug) $161.75
- BEVESPI AEROSPHERE (Drug) $160.29
- Edarbi (Drug) $157.94
- EMGALITY (Drug) $125.61
- REXULTI (Drug) $100.28
- PREMARIN (Drug) $97.00
- LYRICA (Drug) $83.60
- JANUVIA (Drug) $65.39
- Kerendia (Drug) $60.11
- Cologuard Collection Kit (Device) $54.92
- ENTRESTO (Drug) $52.70
- SOLIQUA (Drug) $46.55
- APTIOM (Drug) $44.20
- UBRELVY (Drug) $43.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Athens
Farris Johnson, Md, MD
Family Medicine — Payments: $30,847
Timothy Law, Do, DO
Family Medicine — Payments: $18,254
Dr. Henry Morris, M.d, M.D
Family Medicine — Payments: $16,624
Alvin Wilson, D.o, D.O
Family Medicine — Payments: $13,833
Dr. James Shiver, M.d, M.D
Family Medicine — Payments: $13,306
Dr. Paul Haver, M.d, M.D
Family Medicine — Payments: $11,681